BioSpace News Archive

Business

Optibrium collaborates with Enamine and BioSolveIT to add REAL Space Search Tool to StarDrop

New extension enables researchers to explore the REAL Space of 11 billion readily accessible compounds directly from StarDrop

November 19, 2019
·
5 min read
Policy

OGT continues move into molecular diagnostics markets with MDSAP certification

Oxford Gene Technology, A Sysmex Group Company, is proud to announce that its new facility in Cambridge, UK, has achieved Medical Device Single Audit Program certification of its quality management system

November 19, 2019
·
3 min read
Business

Castor Establishes Advisory Board of Industry Leaders to Maximize the Impact of its Clinical Data Platform

Industry veterans including Craig Lipset will support the Castor’s vision to advance the future of clinical research

November 19, 2019
·
8 min read
PharmaMar has presented results of its antitumor compounds trabectedin and plocabulin at the CTOS Congress

PharmaMar had a notable presence at CTOS with two oral presentations and six posters on trabectedin and two posters on plocabulin.

November 19, 2019
·
6 min read
Drug Development

Myovant’s Prostate Cancer Drug Ready to Submit to FDA Following Positive Trial Results

Myovant announced that its Phase III HERO trial relugolix met its primary endpoint and six key secondary endpoints in advanced prostate cancer.

November 19, 2019
·
2 min read
·
Mark Terry
A conversation with Bob Volkmann, Founder of BioPharma Works– remotely managing multi-functional discovery collaboration | Sponsored

Saurabh Kapure, Vice President, Business Development, USA for Jubilant Biosys, recently sat down with Bob Volkmann, PhD, Founder and Chief Scientific Officer, at BioPharmaWorks.

November 19, 2019
·
14 min read
Business

Up-and-Coming Female Powerhouses of Biotech

Balancing slim chances with a drive for success, each of these women beat the biotech odds.

November 19, 2019
·
3 min read
·
Elizabeth Glasure
Drug Development

Amidst Novartis Takeover Rumors, The Medicines Company Announces Positive Cholesterol Data

Amidst rumors that Novartis might be interested in an acquisition, The Medicines Company announced data from ORION-10, the second of three 19-month Phase III trials of inclisiran for lowering cholesterol.

November 19, 2019
·
2 min read
·
Mark Terry
Abzena Showcases Discovery and Developability Services at PEGS Europe 2019

Bespoke approach generates high affinity antibodies and selects lead candidates with the strongest chances of success in the clinic

November 19, 2019
·
2 min read
Policy

Martin Shkreli Will Continue to Serve Prison Sentence After Supreme Court Denies Appeal

On Monday, the U.S. Supreme Court refused to overturn his seven-year conviction for securities fraud.

November 19, 2019
·
2 min read
·
Alex Keown